Tg Therapeutics (TGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 152 | 152 | 152 | 152 | 152 |
| Gross Profit | 152 | 152 | 152 | 152 | 152 |
| Operating Expenses | 169,207 | 174,552 | 118,864 | 79,121 | 63,332 |
| Operating Income | -169,055 | -174,400 | -118,712 | -78,969 | -63,180 |
| Interest Expense | 5,287 | 877 | 845 | 0 | 0 |
| Other Income | 1,471 | 1,795 | 1,081 | 716 | 231 |
| Pre-tax Income | -172,871 | -173,482 | -118,476 | -78,253 | -62,949 |
| Net Income Continuous | -172,871 | -173,482 | -118,476 | -78,253 | -62,949 |
| Net Income | $-172,871 | $-173,482 | $-118,476 | $-78,253 | $-62,949 |
| EPS Basic Total Ops | -1.96 | -2.30 | -1.91 | -1.60 | -1.38 |
| EPS Basic Continuous Ops | -1.96 | -2.30 | -1.91 | -1.60 | -1.38 |
| EPS Diluted Total Ops | -1.96 | -2.30 | -1.91 | -1.60 | -1.38 |
| EPS Diluted Continuous Ops | -1.96 | -2.30 | -1.91 | -1.60 | -1.38 |
| EPS Diluted Before Non-Recurring Items | -1.83 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-168,440 | $-174,431 | $-118,569 | $-78,447 | $-62,628 |